Please ensure Javascript is enabled for purposes of website accessibility
Search
Accessibility Menu
Beyond Air Stock Quote

Beyond Air (NASDAQ: XAIR)

$1.15
(-3.4%)
-$0.04
Price as of May 10, 2024, 4:00 p.m. ET

Beyond Air Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
XAIR -79.35% -79.46% -27.11% -82%
S&P +26.44% +81.25% +12.62% +115%

Beyond Air Company Info

Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company. It engages in developing a nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. It operates under the Beyond Air and Beyond Cancer segments. The firm developed the LungFit platform system, a generator and delivery system that produces nitric oxide from ambient air, eliminating the need for expensive and cumbersome cylinders. The company was founded in 2011 and is headquartered in Garden City, NY.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.